The outlook of companies tied to iconic drugs like Viagra presents a challenging investment scenario . While the initial surge of copyright, fueled by Viagra's extraordinary popularity, generated substantial returns, the loss of exclusivity in key territories has introduced significant risk . Investors are now assessing the consequences of rival me